Puig has acquired ISDIN, the international pharmaceutical company, for $1.4 billion. This transaction unites a global beauty and fashion group with a leader in dermatological solutions, significantly expanding Puig's footprint in the dermo-cosmetics and medical beauty sectors.
ISDIN, established in 1975, is a prominent pharmaceutical company specializing in dermatology, committed to developing solutions for main dermatology conditions and needs. It holds a leading position in the Spanish dermatology market and has continuously expanded its presence across European, Latin American, and South African markets. The company is known for its strong commitment, alongside dermatologists and pharmacists, to skin treatments and maintenance. Its extensive experience in diseases affecting the skin and mucosa allows it to provide comprehensive solutions for treatment, prevention, and maintenance. Its portfolio includes well-known brands such as Photoprotector ISDIN®, Ureadin, Germisdin, and Nutratopic®, all developed through continuous research and innovation aimed at advanced formulas and new textures.
The integration of ISDIN into Puig's portfolio is expected to create substantial synergies, particularly in research and development, distribution networks, and market reach. ISDIN's deep expertise in dermatological science and its strong relationships within the medical community will complement Puig's global brand-building capabilities and extensive commercial infrastructure. This move allows Puig to diversify its offerings and tap into the growing demand for specialized skin health products, while providing ISDIN with enhanced resources for further international expansion and product innovation, fulfilling its will to become an international reference in skin treatment.
The combined entity is poised to become a more formidable force in the global beauty and personal care industry, with a broadened product range spanning from high-end fragrances and fashion to advanced dermatological treatments. This strategic alignment is anticipated to accelerate growth and reinforce market leadership in key segments, leveraging the strengths of both organizations to deliver innovative solutions to a wider consumer base.